Analysts: Coloplast on steam for record sales

Tomorrow the Danish company Coloplast will publish her past quarter's results. Based on the analysts' consensus: both the revenue and the net result would be on record levels. For this year Coloplast 's revenue will be around 15,75 billion euros. This is according to the average of the analysts' estimates. The expected revenue would be a record for the company. This is slightly more than 2016's revenue of 14,68 billion euros.

Historical revenues and results Coloplast plus estimates 2017

The analysts anticipate for 2017 a record net profit a 3,95 billion euros. For this year the majority of the analysts, consulted by press agency Thomson Reuters, expects a profit per share of 18,75 euros. The price/earnings-ratio therefore equals 29,33.

Per share the analysts expect a dividend of 14,1 euros per share. The dividend yield is then 2,56 percent. The average dividend yield of the pharmaceutical companies equals a low 1,28 percent.

Coloplast 's market capitalization is based on the number of outstanding shares around 106,34 billion euros.

At 11.09 the stock trades 0,36 percent higher at 550 euros.

Historical stock prices Coloplast

ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.